Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long-COVID continues to impact many, with symptoms lasting years in some cases.

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, ...

Cornell researcher Raina Plowright and her team observed that when bats in Australia lost access to their habitat and natural ...

SARS-CoV-2 has been evolving the ability to evade the immune system about twice as fast as the fastest-evolving flu virus. It averages more than a dozen significant changes every year.

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...

Shi Zhengli, a leading virologist, became known as “Bat Woman” for her work on coronaviruses. She has spent decades studying ...

The German government for years concealed an assessment by its Foreign Intelligence Service that a lab origin of COVID-19 was overwhelmingly likely, according ...

A drug called ensitrelvir can help prevent Covid-19 in people who have been exposed within households. This finding comes from an international clinical trial a UVA School of Medicine professor helped ...

As we reflect on five years since the tumultuous start of the COVID pandemic (even if we just wish to forget it ever happened ...